Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | PGK1 | P00558 | 2/20 | 0.31 |
| ▸ | PGK2 | P07205 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6820625 | 0.71 | POLB (0.41) | — | |
| SCHEMBL22652562 | 0.70 | CYP1A2 (0.33) | — | |
| SCHEMBL23815768 | 0.70 | CYP1A2 (0.33) | — | |
| SCHEMBL4197284 | 0.69 | FDPS (0.46) | FDPSPGK1PGK2 | |
| SCHEMBL7870277 | 0.69 | PGK1 (0.44) | FDPSPGK1PGK2 | |
| SCHEMBL512927 | 0.68 | MEN1 (0.55) | — | |
| SCHEMBL8864055 | 0.68 | CHRNA4 (0.32) | — | |
| SCHEMBL1585204 | 0.66 | TSHR (0.41) | FDPSPGK1PGK2 | |
| SCHEMBL11764105 | 0.66 | FDPS (0.39) | FDPS | |
| SCHEMBL1353298 | 0.66 | PGK1 (0.47) | PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040152723-A1 | Pharmaceutical compositions and methods for use | CLARK THOMAS JEFFREY (US) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152723-A1 | Pharmaceutical compositions and methods for use | CHRNA7, CHRNA10, CHRNG | FDPS 1383/4885PGK1 3951/4885PGK2 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.